We proposed an efficient strategy to deliver FADD protein in a controlled manner with the better targeting ability of cancer cells and this therapeutic strategy may be useful to overcome temporal and uncontrolled expression modulation as observed with the conventional gene delivery approach. Here, FADD is linked to cancer.